ASZ Aalst

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?	Arrhythmias, Cardiac, Arterial Occlusive Diseases, Embolism, Embolism and Thrombosis, Hemorrhage, Infarction, Necrosis, Non-ST Elevated Myocardial Infarction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, acute coronary syndrome, arteriosclerosis disorder, atrial fibrillation, atrial flutter, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, coronary artery disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, thrombotic disease, vascular disorder	Recruiting	Phase 4	2023-12-15		NCT04436978
The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent	Arterial Occlusive Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, ischemic disease, myocardial ischemia, vascular disorder	Recruiting	Not applicable	2023-10-30		NCT04923191

Clinical trials